Ann‐Kathrin Bittner

Author

Ann‐Kathrin Bittner

University of Duisburg-Essen ORCID

Also Known As

A Bittner, A K Bittner, A. K. Bittner, ANN-KATHRIN BITTNER, Ann-Kathrin Bittner, Ann‐Kathrin Bittner

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Duisburg-Essen Heinrich Heine University Düsseldorf Essen University Hospital Deutschen Konsortium für Translationale Krebsforschung Düsseldorf University Hospital

About

Ann‐Kathrin Bittner is an author at University of Duisburg-Essen specializing in oncology, breast cancer, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	325
2	Health Sciences	2	2	55
3	Cell Biology	2	2	174
4	Engineering	1	1	34
5	Public Health	1	1	20

Ann‐Kathrin Bittner

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy Lisa König, Sabine Kasimir‐Bauer, Ann‐Kathrin Bittner, OncoImmunology Extracellular VesiclesBreast OncologyTherapy FailureMedicinePathology	2017	128
The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients Lisa König, Sabine Kasimir‐Bauer, Oliver Hoffmann, Human Immunology Vesicular Hla-gBreast OncologyCancer ImmunosurveillanceBreast Cancer PatientsMedicine	2016	82
Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy Sabine Kasimir‐Bauer, Ann‐Kathrin Bittner, Lisa König, Breast Cancer Research	2016	78
Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients Nils Martin Bruckmann, Julian Kirchner, Lale Umutlu, European Radiology	2021	56
Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer Lisa König, Fabian Mairinger, Oliver Hoffmann, BMC Cancer	2019	52
Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer Janna Morawitz, Nils Martin Bruckmann, Frederic Dietzel, European Journal of Nuclear Medicine and Molecular Imaging	2021	51
Multiparametric Integrated 18F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding Lale Umutlu, Julian Kirchner, Nils Martin Bruckmann, Cancers	2021	50
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis Andreas D. Hartkopf, Sara Y. Brucker, Florin‐Andrei Taran, European Journal of Cancer International Pooled AnalysisBreast OncologyBone Marrow FailureMedicineMalignant Blood Disorder	2021	46
Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients Corinna Keup, Karim Benyaa, Siegfried Hauch, Cellular and Molecular Life Sciences	2019	45
Multiparametric 18F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Lale Umutlu, Julian Kirchner, Nils Martin Bruckmann, Cancers	2022	43

Page 1